Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals

BackgroundDrug metabolism genes are involved in the in vivo metabolic processing of drugs. In previous research, we found that a high-fat diet affected the transcript levels of mouse hepatic genes responsible for drug metabolism.AimsOur research intends to discover the drug metabolism genes that are...

Full description

Bibliographic Details
Main Authors: Li Chen, Lu Chen, Xu Li, Lin Qin, Yan Zhu, Qianru Zhang, Daopeng Tan, Yuqi He, Yu-He Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1034494/full
_version_ 1828072273865605120
author Li Chen
Li Chen
Li Chen
Lu Chen
Lu Chen
Xu Li
Xu Li
Lin Qin
Lin Qin
Yan Zhu
Qianru Zhang
Qianru Zhang
Daopeng Tan
Daopeng Tan
Yuqi He
Yuqi He
Yu-He Wang
Yu-He Wang
Yu-He Wang
author_facet Li Chen
Li Chen
Li Chen
Lu Chen
Lu Chen
Xu Li
Xu Li
Lin Qin
Lin Qin
Yan Zhu
Qianru Zhang
Qianru Zhang
Daopeng Tan
Daopeng Tan
Yuqi He
Yuqi He
Yu-He Wang
Yu-He Wang
Yu-He Wang
author_sort Li Chen
collection DOAJ
description BackgroundDrug metabolism genes are involved in the in vivo metabolic processing of drugs. In previous research, we found that a high-fat diet affected the transcript levels of mouse hepatic genes responsible for drug metabolism.AimsOur research intends to discover the drug metabolism genes that are dysregulated at the transcriptome level in nonalcoholic fatty liver disease (NAFLD).MethodsWe analyzed the transcriptome for drug metabolism genes of 35 human liver tissues obtained during laparoscopic cholecystectomy. Additionally, we imported transcriptome data from mice fed a high-fat diet in previous research and two open-access Gene Expression Omnibus (GEO) datasets (GSE63067 and GSE89632). Then, using quantitative real-time polymerase chain reaction (qRT-PCR), we cross-linked the differentially expressed genes (DEGs) in clinical and animal samples and validated the common genes.ResultsIn this study, we identified 35 DEGs, of which 33 were up-regulated and two were down-regulated. Moreover, we found 71 DEGs (39 up- and 32 down-regulated), 276 DEGs (157 up- and 119 down-regulated), and 158 DEGs (117 up- and 41 down-regulated) in the GSE63067, GSE89632, and high-fat diet mice, respectively. Of the 35 DEGs, nine co-regulated DEGs were found in the Venn diagram (CYP20A1, CYP2U1, SLC9A6, SLC26A6, SLC31A1, SLC46A1, SLC46A3, SULT1B1, and UGT2A3).ConclusionNine significant drug metabolism genes were identified in NAFLD. Future research should investigate the impacts of these genes on drug dose adjustment in patients with NAFLD.Clinical Trial Registrationhttp://www.chictr.org.cn, identifier ChiCTR2100041714.
first_indexed 2024-04-11T01:06:57Z
format Article
id doaj.art-dde4ba40228b42fb84c09674ca96229d
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-11T01:06:57Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-dde4ba40228b42fb84c09674ca96229d2023-01-04T12:12:37ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922023-01-011310.3389/fendo.2022.10344941034494Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animalsLi Chen0Li Chen1Li Chen2Lu Chen3Lu Chen4Xu Li5Xu Li6Lin Qin7Lin Qin8Yan Zhu9Qianru Zhang10Qianru Zhang11Daopeng Tan12Daopeng Tan13Yuqi He14Yuqi He15Yu-He Wang16Yu-He Wang17Yu-He Wang18Department of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi,  ChinaThe Key Laboratory of the Ministry of Education of the Basic Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Key Laboratory of the Ministry of Education of the Basic Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Key Laboratory of the Ministry of Education of the Basic Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Key Laboratory of the Ministry of Education of the Basic Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaDepartment of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi,  ChinaThe Key Laboratory of the Ministry of Education of the Basic Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Key Laboratory of the Ministry of Education of the Basic Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Key Laboratory of the Ministry of Education of the Basic Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaDepartment of Pharmacy, Affiliated Hospital of Zunyi Medical University, Zunyi,  ChinaThe Key Laboratory of the Ministry of Education of the Basic Pharmacology, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaThe Joint International Research Laboratory of Ethnomedicine of the Ministry of Education, School of Pharmacy, Zunyi Medical University, Zunyi,  ChinaBackgroundDrug metabolism genes are involved in the in vivo metabolic processing of drugs. In previous research, we found that a high-fat diet affected the transcript levels of mouse hepatic genes responsible for drug metabolism.AimsOur research intends to discover the drug metabolism genes that are dysregulated at the transcriptome level in nonalcoholic fatty liver disease (NAFLD).MethodsWe analyzed the transcriptome for drug metabolism genes of 35 human liver tissues obtained during laparoscopic cholecystectomy. Additionally, we imported transcriptome data from mice fed a high-fat diet in previous research and two open-access Gene Expression Omnibus (GEO) datasets (GSE63067 and GSE89632). Then, using quantitative real-time polymerase chain reaction (qRT-PCR), we cross-linked the differentially expressed genes (DEGs) in clinical and animal samples and validated the common genes.ResultsIn this study, we identified 35 DEGs, of which 33 were up-regulated and two were down-regulated. Moreover, we found 71 DEGs (39 up- and 32 down-regulated), 276 DEGs (157 up- and 119 down-regulated), and 158 DEGs (117 up- and 41 down-regulated) in the GSE63067, GSE89632, and high-fat diet mice, respectively. Of the 35 DEGs, nine co-regulated DEGs were found in the Venn diagram (CYP20A1, CYP2U1, SLC9A6, SLC26A6, SLC31A1, SLC46A1, SLC46A3, SULT1B1, and UGT2A3).ConclusionNine significant drug metabolism genes were identified in NAFLD. Future research should investigate the impacts of these genes on drug dose adjustment in patients with NAFLD.Clinical Trial Registrationhttp://www.chictr.org.cn, identifier ChiCTR2100041714.https://www.frontiersin.org/articles/10.3389/fendo.2022.1034494/fullnonalcoholic fatty liver diseasetranscriptomedrug metabolism genesGEO datasetshigh-fat diet
spellingShingle Li Chen
Li Chen
Li Chen
Lu Chen
Lu Chen
Xu Li
Xu Li
Lin Qin
Lin Qin
Yan Zhu
Qianru Zhang
Qianru Zhang
Daopeng Tan
Daopeng Tan
Yuqi He
Yuqi He
Yu-He Wang
Yu-He Wang
Yu-He Wang
Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals
Frontiers in Endocrinology
nonalcoholic fatty liver disease
transcriptome
drug metabolism genes
GEO datasets
high-fat diet
title Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals
title_full Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals
title_fullStr Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals
title_full_unstemmed Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals
title_short Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals
title_sort transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease a study of human and animals
topic nonalcoholic fatty liver disease
transcriptome
drug metabolism genes
GEO datasets
high-fat diet
url https://www.frontiersin.org/articles/10.3389/fendo.2022.1034494/full
work_keys_str_mv AT lichen transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT lichen transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT lichen transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT luchen transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT luchen transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT xuli transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT xuli transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT linqin transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT linqin transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT yanzhu transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT qianruzhang transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT qianruzhang transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT daopengtan transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT daopengtan transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT yuqihe transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT yuqihe transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT yuhewang transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT yuhewang transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals
AT yuhewang transcriptomicprofilingofhepatictissuesfordrugmetabolismgenesinnonalcoholicfattyliverdiseaseastudyofhumanandanimals